Eric Karas
Corporate Officer/Principal at ARS PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Eric Karas is currently the Chief Commercial Officer at ARS Subsidiary, Inc. and ARS Pharmaceuticals, Inc. He previously worked as the Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. Mr. Karas has an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-01 | 0 ( -.--% ) | - $ | 2024-03-30 |
Eric Karas active positions
Companies | Position | Start |
---|---|---|
ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-11-07 |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2022-03-31 |
Former positions of Eric Karas
Companies | Position | End |
---|---|---|
EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 2022-02-28 |
Training of Eric Karas
Rutgers State University of New Jersey | Undergraduate Degree |
Eli Broad College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
EMERGENT BIOSOLUTIONS INC. | Health Technology |
Private companies | 2 |
---|---|
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
ARS Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Eric Karas